Human important anti-apoptotic molecules Bcl-xL and Mcl-1 are determined to be new direct targets of miR-133a in osteosarcoma, indicating that miR-133a may exert its pro-apoptotic function throughout inhibiting Bcl-xL and Mcl-1 expression. Here, BCL2L1 is linked to osteosarcoma.